FDA panel to review Qnexa in February 2012

December 23, 2011

The Food and Drug Administration's Endocrinologic and Metabolic Drugs Advisory Committee is set to review an investigational treatment for obesity.

Want to Read More?

This content is available only to registered users. Log in to read the rest of this article or create a free account.

Or, Create an Account >>

Comments

I would love to see this work

I would love to see this work for obesity. I hope to see more research done on this and get approved. There is so many people dealing with this and need help.

Apr 30, 2012 - 07:45

arnold steveni says:

I think that nowadays lot of

I think that nowadays lot of people are facing the problem of obesity and hence such type of FDA panels will really be helpful for them.
Regards,
Arnold Steveni

Feb 17, 2012 - 03:01

Donny Ringold says:

I has been that Qnexa and the other drugs would provide effective weight-loss without the dangerous side effects such as Fen-phen, Meridia and Alli. But FDA recently warned consumers about Alli's link to severe liver damage. I mean that sounds pretty dangerous. So stay away.

Feb 16, 2012 - 05:19

Ned Phan says:

The drug should completely

The drug should completely and thoroughly be reviewed and checked before it is introduced in the market..Many people will be waiting for this drug to be launched in the market as so many are facing the problem of obesity.

Dec 24, 2011 - 02:35

drjone says:

It is really anyones guess as

It is really anyones guess as to what will happen here.
If this is not prescribed to any woman who could become pregnant, I don't see the problem.

Feb 14, 2012 - 07:02

arnold steveni says:

I guess that something great

I guess that something great and beneficial is going to happen here in this panel.I would like to recommend this to my friends and also to peolpe who are facing the problem of obesity.